Important Updates on DOXIL Supply Shortage
Rexahn Pharmaceuticals Submits Archexin Phase II Protocol for Ovarian Canc
Brasser Research Center to Focus on BRCA Cancer Genes
Fallopian tube removal may lower risk of deadly ovarian cancer
Venus Remedies developing new cancer drug delivery technology
more »